Company: DHR
Filing Date: 2025-03-26
Form Type: DEF 14A
Source: 0000313616-25-000081
Chunk: 14

Company: DANAHER CORP /DE/
Filing Date: 2025-03-26
Form: DEF 14A
Chunk 14
---
 addition, in the event of a significant cybersecurity incident, Danaher policy and process requires timely engagement of and consultation with the Audit Committee. |

| 2025 Notice of Annual Meeting and Proxy Statement |     | 22 |

Board of Directors and Committees of the Board

General

The Board met five times in 2024. All directors attended at least 88% (and eleven of the directors attended 100%) of the total number of meetings of the Board and of the committees of the Board on which they served held during the period they served. Danaher typically schedules a Board meeting in conjunction with each annual meeting of shareholders and as a general matter expects that the members of the Board will attend the annual meeting. All of our directors at the time attended the Company’s annual meeting in May 2024.

The membership of each of the Board’s committees as of March 1, 2025 is set forth below. While each of the committees is authorized to delegate its powers to sub-committees, none of the committees did so during 2024. The Audit, Compensation, Nominating & Governance and Science & Technology Committees report to the Board on their actions and recommendations at each regularly scheduled Board meeting. Each such committee typically meets in executive session, without the presence of management, at its regularly scheduled meetings.

| Name of Director           |     | Audit |     | Compensation |     | Nominating & Governance |     | Science & Technology |     | Executive |     | Finance |
| Rainer M. Blair            |     |       |     |              |     |                         |     |                      |     |           |     |         |
| Feroz Dewan                |     |       |     |              |     |                         |     |                      |     |           |     |         |
| Linda Filler               |     |       |     |              |     |                         |     |                      |     |           |     |         |
| Charles W. Lamanna         |     |       |     |              |     |                         |     |                      |     |           |     |         |
| Teri List                  |     |       |     |              |     |                         |     |                      |     |           |     |         |
| Jessica L. Mega, MD, MPH   |     |       |     |              |     |                         |     |                      |     |           |     |         |
| Mitchell P. Rales          |     |       |     |              |     |